ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis. Two years since coming to the US, the company has ...
Heart disease is becoming increasingly common and can affect people of all ages. According to the World Health Organization (WHO), it remains the leading cause of death worldwide, claiming nearly 17.9 ...